Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2014 · —
Revenue$1.78B$1.78B+4.2% vs Q1 2013 Net Income$133.00M$133.00MN/M vs Q1 2013 EPS Diluted$0.10$0.10N/M vs Q1 2013 Gross Profit$1,237,000,000+4.6% Operating Income$197,000,000N/M Operating Cash Flow$198,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
+5.9%
Free Cash Flowderived$139,000,000+3.7% Margins · derivedGross margin69.6%+0.2 pt vs Q1 2013
Operating margin11.1%+30.4 pt vs Q1 2013
Net margin7.5%+28.2 pt vs Q1 2013